Byooviz Den Europæiske Union - dansk - EMA (European Medicines Agency)

byooviz

samsung bioepis nl b.v. - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; myopia, degenerative - oftalmologiske - byooviz is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).

Biquetan 150 mg depottabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

biquetan 150 mg depottabletter

stada arzneimittel ag - quetiapin fumarat - depottabletter - 150 mg

Biquetan 200 mg depottabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

biquetan 200 mg depottabletter

stada arzneimittel ag - quetiapin fumarat - depottabletter - 200 mg

Biquetan 300 mg depottabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

biquetan 300 mg depottabletter

stada arzneimittel ag - quetiapin fumarat - depottabletter - 300 mg

Biquetan 400 mg depottabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

biquetan 400 mg depottabletter

stada arzneimittel ag - quetiapin fumarat - depottabletter - 400 mg